This episode breaks down the mandatory FDA requirement for foreign medical device manufacturers to appoint a U.S. Agent. We explore the specific roles, responsibilities, and qualifications of a U.S. Agent, clarifying their function as the essential communication link between your company and the FDA. Learn the key differences between a U.S. Agent and an Official Correspondent and understand the strategic considerations when choosing your representative to ensure smooth entry into the U.S. market. Key Questions: • What is the primary role of an FDA U.S. Agent? • Is appointing a U.S. Agent an optional or mandatory step for market entry? • Who is required to designate a U.S. Agent? • What are the specific responsibilities of a U.S. Agent during FDA interactions? • How does a U.S. Agent differ from an Official Correspondent? • What are the risks of appointing a distributor as your U.S. Agent? • What duties is a U.S. Agent *not* responsible for? • How is a U.S. Agent officially designated with the FDA? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.